Plerixafor and G-CSF for Mobilization

The study protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Diagnostic Test Accuracy (PRISMA-DTA) statement and was registered in the PROSPERO database (ID: CRD42023425760) in May 2023. We searched the database using the following term: ‘plerixafor’, ‘AMD3100’, ‘G-CSF’, and ‘granulocyte colony-stimulating factor’. PubMed, Embase, Cochrane, and Web of Science databases were searched for potentially relevant studies in English-language articles (up to May 1, 2023). References to the identified articles were also searched to supplement the data sources.

Free full text: Click here

Li Y., Qiu X., Lei Y, & Zhou R. (2024). G-CSF + plerixafor versus G-CSF alone mobilized hematopoietic stem cells in patients with multiple myeloma and lymphoma: a systematic review and meta-analysis. Annals of Medicine, 56(1), 2329140.

Publication 2024

Corresponding Organization :

Other organizations : West China Second University Hospital of Sichuan University, Sichuan University

Top 5 similar protocols

Variable analysis

independent variables

Plerixafor
AMD3100
G-CSF
Granulocyte colony-stimulating factor

dependent variables

not explicitly mentioned

control variables

not explicitly mentioned

controls

Not specified
Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!